Agriculture
Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Research Report 2025
- Mar 11, 25
- ID: 54016
- Pages: 76
- Figures: 77
- Views: 11
The global market for Inactivated Porcine Atrophic Rhinitis Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Inactivated Porcine Atrophic Rhinitis Vaccine in Sows is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology, Tianjin Ringpu Bio-Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Atrophic Rhinitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Atrophic Rhinitis Vaccine.
The Inactivated Porcine Atrophic Rhinitis Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Porcine Atrophic Rhinitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Atrophic Rhinitis Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
HIPRA
Bioveta
China Animal Husbandy Industry
Wuhan Keqian Biology
Pulike Bio-Engineering
Tiankang Animal Science Bio-Technology
Tianjin Ringpu Bio-Technology
Segment by Type
Tissue Culture Origin
Cell Line Origin
Segment by Application
Sows
Gilts
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Inactivated Porcine Atrophic Rhinitis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Inactivated Porcine Atrophic Rhinitis Vaccine in Sows is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Inactivated Porcine Atrophic Rhinitis Vaccine include Merck Animal Health, HIPRA, Bioveta, China Animal Husbandy Industry, Wuhan Keqian Biology, Pulike Bio-Engineering, Tiankang Animal Science Bio-Technology, Tianjin Ringpu Bio-Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Atrophic Rhinitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Atrophic Rhinitis Vaccine.
The Inactivated Porcine Atrophic Rhinitis Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Porcine Atrophic Rhinitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Porcine Atrophic Rhinitis Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Animal Health
HIPRA
Bioveta
China Animal Husbandy Industry
Wuhan Keqian Biology
Pulike Bio-Engineering
Tiankang Animal Science Bio-Technology
Tianjin Ringpu Bio-Technology
Segment by Type
Tissue Culture Origin
Cell Line Origin
Segment by Application
Sows
Gilts
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inactivated Porcine Atrophic Rhinitis Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Market by Application
1.3.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Sows
1.3.3 Gilts
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Perspective (2020-2031)
2.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Growth Trends by Region
2.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Dynamics
2.3.1 Inactivated Porcine Atrophic Rhinitis Vaccine Industry Trends
2.3.2 Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
2.3.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
2.3.4 Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue
3.1.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue (2020-2025)
3.1.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue
3.4 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2024
3.5 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine Head office and Area Served
3.6 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
3.7 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Type
4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2026-2031)
5 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Application
5.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
6.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
6.4 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
7.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
7.4 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
9.2 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
9.4 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Details
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.1.4 Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.1.5 Merck Animal Health Recent Development
11.2 HIPRA
11.2.1 HIPRA Company Details
11.2.2 HIPRA Business Overview
11.2.3 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.2.4 HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.2.5 HIPRA Recent Development
11.3 Bioveta
11.3.1 Bioveta Company Details
11.3.2 Bioveta Business Overview
11.3.3 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.3.4 Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.3.5 Bioveta Recent Development
11.4 China Animal Husbandy Industry
11.4.1 China Animal Husbandy Industry Company Details
11.4.2 China Animal Husbandy Industry Business Overview
11.4.3 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.4.4 China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.4.5 China Animal Husbandy Industry Recent Development
11.5 Wuhan Keqian Biology
11.5.1 Wuhan Keqian Biology Company Details
11.5.2 Wuhan Keqian Biology Business Overview
11.5.3 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.5.4 Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.5.5 Wuhan Keqian Biology Recent Development
11.6 Pulike Bio-Engineering
11.6.1 Pulike Bio-Engineering Company Details
11.6.2 Pulike Bio-Engineering Business Overview
11.6.3 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.6.4 Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.6.5 Pulike Bio-Engineering Recent Development
11.7 Tiankang Animal Science Bio-Technology
11.7.1 Tiankang Animal Science Bio-Technology Company Details
11.7.2 Tiankang Animal Science Bio-Technology Business Overview
11.7.3 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.7.4 Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.7.5 Tiankang Animal Science Bio-Technology Recent Development
11.8 Tianjin Ringpu Bio-Technology
11.8.1 Tianjin Ringpu Bio-Technology Company Details
11.8.2 Tianjin Ringpu Bio-Technology Business Overview
11.8.3 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.8.4 Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.8.5 Tianjin Ringpu Bio-Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Market by Application
1.3.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Sows
1.3.3 Gilts
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Perspective (2020-2031)
2.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Growth Trends by Region
2.2.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Region (2020-2025)
2.2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2026-2031)
2.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Dynamics
2.3.1 Inactivated Porcine Atrophic Rhinitis Vaccine Industry Trends
2.3.2 Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
2.3.3 Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
2.3.4 Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue
3.1.1 Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Revenue (2020-2025)
3.1.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Players (2020-2025)
3.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue
3.4 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio
3.4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2024
3.5 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine Head office and Area Served
3.6 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
3.7 Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Type
4.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Type (2020-2025)
4.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2026-2031)
5 Inactivated Porcine Atrophic Rhinitis Vaccine Breakdown Data by Application
5.1 Global Inactivated Porcine Atrophic Rhinitis Vaccine Historic Market Size by Application (2020-2025)
5.2 Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
6.2 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
6.4 North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
7.2 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
7.4 Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
8.2 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025)
8.4 Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
9.2 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
9.4 Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (2020-2031)
10.2 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025)
10.4 Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Animal Health
11.1.1 Merck Animal Health Company Details
11.1.2 Merck Animal Health Business Overview
11.1.3 Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.1.4 Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.1.5 Merck Animal Health Recent Development
11.2 HIPRA
11.2.1 HIPRA Company Details
11.2.2 HIPRA Business Overview
11.2.3 HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.2.4 HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.2.5 HIPRA Recent Development
11.3 Bioveta
11.3.1 Bioveta Company Details
11.3.2 Bioveta Business Overview
11.3.3 Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.3.4 Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.3.5 Bioveta Recent Development
11.4 China Animal Husbandy Industry
11.4.1 China Animal Husbandy Industry Company Details
11.4.2 China Animal Husbandy Industry Business Overview
11.4.3 China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.4.4 China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.4.5 China Animal Husbandy Industry Recent Development
11.5 Wuhan Keqian Biology
11.5.1 Wuhan Keqian Biology Company Details
11.5.2 Wuhan Keqian Biology Business Overview
11.5.3 Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.5.4 Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.5.5 Wuhan Keqian Biology Recent Development
11.6 Pulike Bio-Engineering
11.6.1 Pulike Bio-Engineering Company Details
11.6.2 Pulike Bio-Engineering Business Overview
11.6.3 Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.6.4 Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.6.5 Pulike Bio-Engineering Recent Development
11.7 Tiankang Animal Science Bio-Technology
11.7.1 Tiankang Animal Science Bio-Technology Company Details
11.7.2 Tiankang Animal Science Bio-Technology Business Overview
11.7.3 Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.7.4 Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.7.5 Tiankang Animal Science Bio-Technology Recent Development
11.8 Tianjin Ringpu Bio-Technology
11.8.1 Tianjin Ringpu Bio-Technology Company Details
11.8.2 Tianjin Ringpu Bio-Technology Business Overview
11.8.3 Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Introduction
11.8.4 Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
11.8.5 Tianjin Ringpu Bio-Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tissue Culture Origin
Table 3. Key Players of Cell Line Origin
Table 4. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2020-2025)
Table 8. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2026-2031)
Table 10. Inactivated Porcine Atrophic Rhinitis Vaccine Market Trends
Table 11. Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
Table 12. Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
Table 13. Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
Table 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players (2020-2025)
Table 16. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2024)
Table 17. Ranking of Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Headquarters and Area Served
Table 20. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
Table 21. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2020-2025)
Table 25. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2026-2031)
Table 27. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2020-2025)
Table 29. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2026-2031)
Table 31. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Animal Health Company Details
Table 47. Merck Animal Health Business Overview
Table 48. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 49. Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 50. Merck Animal Health Recent Development
Table 51. HIPRA Company Details
Table 52. HIPRA Business Overview
Table 53. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 54. HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 55. HIPRA Recent Development
Table 56. Bioveta Company Details
Table 57. Bioveta Business Overview
Table 58. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 59. Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 60. Bioveta Recent Development
Table 61. China Animal Husbandy Industry Company Details
Table 62. China Animal Husbandy Industry Business Overview
Table 63. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 64. China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 65. China Animal Husbandy Industry Recent Development
Table 66. Wuhan Keqian Biology Company Details
Table 67. Wuhan Keqian Biology Business Overview
Table 68. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 69. Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 70. Wuhan Keqian Biology Recent Development
Table 71. Pulike Bio-Engineering Company Details
Table 72. Pulike Bio-Engineering Business Overview
Table 73. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 74. Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 75. Pulike Bio-Engineering Recent Development
Table 76. Tiankang Animal Science Bio-Technology Company Details
Table 77. Tiankang Animal Science Bio-Technology Business Overview
Table 78. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 79. Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 80. Tiankang Animal Science Bio-Technology Recent Development
Table 81. Tianjin Ringpu Bio-Technology Company Details
Table 82. Tianjin Ringpu Bio-Technology Business Overview
Table 83. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 84. Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 85. Tianjin Ringpu Bio-Technology Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Inactivated Porcine Atrophic Rhinitis Vaccine Picture
Figure 2. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Tissue Culture Origin Features
Figure 5. Cell Line Origin Features
Figure 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Sows Case Studies
Figure 9. Gilts Case Studies
Figure 10. Inactivated Porcine Atrophic Rhinitis Vaccine Report Years Considered
Figure 11. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region: 2024 VS 2031
Figure 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players in 2024
Figure 15. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2024
Figure 17. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 19. United States Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 23. Germany Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2020-2031)
Figure 31. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 39. Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 43. Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Merck Animal Health Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 47. HIPRA Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 48. Bioveta Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 49. China Animal Husbandy Industry Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 50. Wuhan Keqian Biology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 51. Pulike Bio-Engineering Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 52. Tiankang Animal Science Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 53. Tianjin Ringpu Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tissue Culture Origin
Table 3. Key Players of Cell Line Origin
Table 4. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2020-2025)
Table 8. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2026-2031)
Table 10. Inactivated Porcine Atrophic Rhinitis Vaccine Market Trends
Table 11. Inactivated Porcine Atrophic Rhinitis Vaccine Market Drivers
Table 12. Inactivated Porcine Atrophic Rhinitis Vaccine Market Challenges
Table 13. Inactivated Porcine Atrophic Rhinitis Vaccine Market Restraints
Table 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players (2020-2025)
Table 16. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2024)
Table 17. Ranking of Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Headquarters and Area Served
Table 20. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Product and Application
Table 21. Global Key Players of Inactivated Porcine Atrophic Rhinitis Vaccine, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2020-2025)
Table 25. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Type (2026-2031)
Table 27. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2020-2025)
Table 29. Global Inactivated Porcine Atrophic Rhinitis Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Inactivated Porcine Atrophic Rhinitis Vaccine Revenue Market Share by Application (2026-2031)
Table 31. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck Animal Health Company Details
Table 47. Merck Animal Health Business Overview
Table 48. Merck Animal Health Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 49. Merck Animal Health Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 50. Merck Animal Health Recent Development
Table 51. HIPRA Company Details
Table 52. HIPRA Business Overview
Table 53. HIPRA Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 54. HIPRA Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 55. HIPRA Recent Development
Table 56. Bioveta Company Details
Table 57. Bioveta Business Overview
Table 58. Bioveta Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 59. Bioveta Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 60. Bioveta Recent Development
Table 61. China Animal Husbandy Industry Company Details
Table 62. China Animal Husbandy Industry Business Overview
Table 63. China Animal Husbandy Industry Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 64. China Animal Husbandy Industry Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 65. China Animal Husbandy Industry Recent Development
Table 66. Wuhan Keqian Biology Company Details
Table 67. Wuhan Keqian Biology Business Overview
Table 68. Wuhan Keqian Biology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 69. Wuhan Keqian Biology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 70. Wuhan Keqian Biology Recent Development
Table 71. Pulike Bio-Engineering Company Details
Table 72. Pulike Bio-Engineering Business Overview
Table 73. Pulike Bio-Engineering Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 74. Pulike Bio-Engineering Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 75. Pulike Bio-Engineering Recent Development
Table 76. Tiankang Animal Science Bio-Technology Company Details
Table 77. Tiankang Animal Science Bio-Technology Business Overview
Table 78. Tiankang Animal Science Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 79. Tiankang Animal Science Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 80. Tiankang Animal Science Bio-Technology Recent Development
Table 81. Tianjin Ringpu Bio-Technology Company Details
Table 82. Tianjin Ringpu Bio-Technology Business Overview
Table 83. Tianjin Ringpu Bio-Technology Inactivated Porcine Atrophic Rhinitis Vaccine Product
Table 84. Tianjin Ringpu Bio-Technology Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025) & (US$ Million)
Table 85. Tianjin Ringpu Bio-Technology Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Inactivated Porcine Atrophic Rhinitis Vaccine Picture
Figure 2. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Type: 2024 VS 2031
Figure 4. Tissue Culture Origin Features
Figure 5. Cell Line Origin Features
Figure 6. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Application: 2024 VS 2031
Figure 8. Sows Case Studies
Figure 9. Gilts Case Studies
Figure 10. Inactivated Porcine Atrophic Rhinitis Vaccine Report Years Considered
Figure 11. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region: 2024 VS 2031
Figure 14. Global Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Players in 2024
Figure 15. Global Top Inactivated Porcine Atrophic Rhinitis Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Porcine Atrophic Rhinitis Vaccine as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Inactivated Porcine Atrophic Rhinitis Vaccine Revenue in 2024
Figure 17. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 19. United States Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 23. Germany Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Region (2020-2031)
Figure 31. China Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 39. Mexico Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Inactivated Porcine Atrophic Rhinitis Vaccine Market Share by Country (2020-2031)
Figure 43. Turkey Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Inactivated Porcine Atrophic Rhinitis Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Merck Animal Health Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 47. HIPRA Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 48. Bioveta Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 49. China Animal Husbandy Industry Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 50. Wuhan Keqian Biology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 51. Pulike Bio-Engineering Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 52. Tiankang Animal Science Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 53. Tianjin Ringpu Bio-Technology Revenue Growth Rate in Inactivated Porcine Atrophic Rhinitis Vaccine Business (2020-2025)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232